Go Back   HER2 Support Group Forums > Profiles In Courage
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 04-27-2012, 11:02 PM   #1
Senior Member
Rich66's Avatar
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Video helps woman with aggressive breast cancer get experimental drug (pertuzumab)


The company told her the drug wouldn't be available until June. Gant didn't expect to live that long. So her husband recorded an online plea.

Three weeks after Gant's emotional video hit YouTube, the 20 minute clip went viral. And Gant got her wish.

In an unusual move, the pharmaceutical company agreed to give her the medication.

"It's generally not done with a patient initiative, it's generally through a physician," said Dr. Michael Hayes, PharmD at Moffitt Cancer Center in Tampa. "This is pretty unusual in this fact that it's gone pretty much national in this regard."
Rich66 is offline   Reply With Quote
Old 04-30-2012, 12:58 PM   #2
Senior Member
gdpawel's Avatar
Join Date: Aug 2006
Location: Pennsylvania
Posts: 1,080
Re: Video helps woman with aggressive breast cancer get experimental drug (pertuzumab

The novel monoclonal antibody pertuzumab functions by preventing dimerization of HER-2 (the target of Herceptin) with the other members of the human epidermal growth factor family HER-1, HER-3 and HER-4. In so doing, the cross talk between receptors is abrogated and downstream signaling is squelched. One of the most interesting aspect of the reports on this drug is it reflects the downstream pathways it targets. Pertuzumab inhibits signaling at the PI3K pathway, upstream from mTOR.

This, in the truest sense, is a breakthrough in metabolomics. There may be many reasons why cancer drugs remain out of reach for patients like this, and the Gant video illustrates how social media can change the equation, but several changes could be implemented immediately to increase the rate of success of these new drugs. One of them is the need to redouble the efforts in the study of basic metabolism and the growing field of metabolomics (the metabolome). For personalizing cancer therapy for patients, metabolic profiles are essential. She should have received “active” drugs, the first time around, and doctors should be allowed to give them, using techniques that match patients to “active” therapies.
gdpawel is offline   Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

All times are GMT -7. The time now is 11:10 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter